Literature DB >> 34250287

Effects of COVID-19 vaccination on FDG-PET/CT imaging: A literature review.

Ryogo Minamimoto1, Tomomichi Kiyomatsu2.   

Abstract

COVID-19 vaccination using mRNA technology began at the end of 2020 in several countries, approximately 9 months after the WHO declared the new coronavirus a pandemic, and began in Japan at the end of February 2021. Several studies have reported FDG avidity in enlarged axillary lymph nodes as a specific feature of FDG-PET/CT imaging after COVID-19 vaccination. A major concern is that this finding could lead to a misdiagnosis in patients with various types of malignancy. We review the impact of COVID-19 vaccination on the management of patients scheduled for FDG-PET/CT in the setting of nationwide mass vaccination. 2021, National Center for Global Health and Medicine.

Entities:  

Keywords:  COVID-19; FDG; PET/CT; vaccine

Year:  2021        PMID： 34250287      PMCID： PMC8239370          DOI： 10.35772/ghm.2021.01076

Source DB:  PubMed          Journal:  Glob Health Med        ISSN： 2434-9186


  35 in total

Review 1.  Molecular imaging of cancer with positron emission tomography.

Authors:  Sanjiv Sam Gambhir
Journal:  Nat Rev Cancer       Date:  2002-09       Impact factor: 60.716

2.  FDG uptake in axillary lymph nodes after vaccination against pandemic (H1N1).

Authors:  Emmanouil Panagiotidis; Demetrios Exarhos; Irene Housianakou; Apostolos Bournazos; Ioannis Datseris
Journal:  Eur Radiol       Date:  2010-02-26       Impact factor: 5.315

3.  Duration of 18F-FDG avidity in lymph nodes after pandemic H1N1v and seasonal influenza vaccination.

Authors:  Anders Thomassen; Anne Lerberg Nielsen; Oke Gerke; Allan Johansen; Henrik Petersen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-22       Impact factor: 9.236

Review 4.  mRNA vaccines - a new era in vaccinology.

Authors:  Norbert Pardi; Michael J Hogan; Frederick W Porter; Drew Weissman
Journal:  Nat Rev Drug Discov       Date:  2018-01-12       Impact factor: 84.694

5.  Sustaining containment of COVID-19: global sharing for pandemic response.

Authors:  Hiroaki Mitsuya; Norihiro Kokudo
Journal:  Glob Health Med       Date:  2020-04-30

Review 6.  Coordination and optimization of FDG PET/CT and COVID-19 vaccination; Lessons learned in the early stages of mass vaccination.

Authors:  Lacey J McIntosh; Max P Rosen; Kriti Mittal; Giles F Whalen; Venu G Bathini; Tasneem Ali; Kathryn L Edmiston; William V Walsh; Jonathan M Gerber
Journal:  Cancer Treat Rev       Date:  2021-05-11       Impact factor: 12.111

7.  COVID arm and PET/FDG imaging.

Authors:  Jérôme Barriere; Michaël Bondouy
Journal:  Bull Cancer       Date:  2021-05-07       Impact factor: 1.276

8.  Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.

Authors:  Lindsey R Baden; Hana M El Sahly; Brandon Essink; Karen Kotloff; Sharon Frey; Rick Novak; David Diemert; Stephen A Spector; Nadine Rouphael; C Buddy Creech; John McGettigan; Shishir Khetan; Nathan Segall; Joel Solis; Adam Brosz; Carlos Fierro; Howard Schwartz; Kathleen Neuzil; Larry Corey; Peter Gilbert; Holly Janes; Dean Follmann; Mary Marovich; John Mascola; Laura Polakowski; Julie Ledgerwood; Barney S Graham; Hamilton Bennett; Rolando Pajon; Conor Knightly; Brett Leav; Weiping Deng; Honghong Zhou; Shu Han; Melanie Ivarsson; Jacqueline Miller; Tal Zaks
Journal:  N Engl J Med       Date:  2020-12-30       Impact factor: 91.245

9.  Immune Response Visualized In Vivo by [18F]-FDG PET/CT after COVID-19 Vaccine.

Authors:  Romain-David Seban; Laurence Champion; Nicolas Deleval; Capucine Richard; Claire Provost
Journal:  Diagnostics (Basel)       Date:  2021-04-09

10.  COVID-19 vaccination induced axillary nodal uptake on [18F]FDG PET/CT.

Authors:  Ayah Adel Nawwar; Julie Searle; Ian Hagan; Iain Douglas Lyburn
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-26       Impact factor: 10.057
View more
  5 in total

1.  Change in cancer diagnosis during the COVID-19 pandemic: Trends estimated from FDG-PET/CT.

Authors:  Ryogo Minamimoto; Masatoshi Hotta; Takashi Okafuji; Soichiro Tsutui; Masaaki Tsukuda; Hidetsugu Nakayama; Yoshitaka Shida; Tsuyoshi Tajima
Journal:  Glob Health Med       Date:  2022-04-30

Review 2.  What Should We Do after the COVID-19 Vaccination? Vaccine-Associated Diseases and Precautionary Measures against Adverse Reactions.

Authors:  Toru Awaya; Masao Moroi; Yoshinari Enomoto; Taeko Kunimasa; Masato Nakamura
Journal:  Vaccines (Basel)       Date:  2022-05-28

3.  [18F]FDG uptake in axillary lymph nodes and deltoid muscle after COVID-19 mRNA vaccination: a cohort study to determine incidence and contributing factors using a multivariate analysis.

Authors:  Kazuo Kubota; Toshiyuki Saginoya; Kiichi Ishiwata; Tatsuhiko Nakasato; Hirotsugu Munechika
Journal:  Ann Nucl Med       Date:  2022-01-31       Impact factor: 2.258

4.  Incidental Finding of Moderna COVID-19 Vaccination-Related Axillary Lymphadenopathy on 201Tl Myocardial Perfusion Imaging.

Authors:  Hung-Pin Chan; Daniel Hueng-Yuan Shen; Ming-Hui Yang; Chin Hu; Yu-Chang Tyan
Journal:  Clin Nucl Med       Date:  2022-03-01       Impact factor: 7.794

5.  Systemic Immune Response Syndrome After COVID-19 Immunization-Initial and Follow-up 18F-FDG PET/CT Imaging Appearances.

Authors:  Ayah Adel Nawwar; Julie Searle; Ian Hagan; Iain Douglas Lyburn
Journal:  Clin Nucl Med       Date:  2022-03-01       Impact factor: 7.794
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.